Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-fugetactic agents for the treatment of ovarian cancer

Anti-fugetactic agents for the treatment of ovarian cancer

US Patent 9789171 · Granted Oct 17, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Localized delivery of anti-fugetactic agent for treatment of cancer2024
Antigen-binding fusion proteins with modified HSP70 domains2023
Coxiella burnetii epitopes for T cell-targeted Q fever vaccines2023
CXCR4/CXCR7 blockade and treatment of human papilloma virus-associated disease2023
HSP fusion protein with anti-chemorepellant agent for treatment of infectious di2022
Modified natural killer cells for the treatment of cancer2022
Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment 2022
HSP fusion protein with anti-chemorepellant agent for treatment of cancer2022
Anti-fugetactic agent and anti-cancer agent combination therapy and compositions2022
Method of treating cervical neoplasia in patients infected with human papilloma 2021
Immunotherapies employing self-assembling vaccines2020
Eluting matrix and uses thereof2020